|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
47,380,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Inhibrx is a clinical-stage biotechnology company with a pipeline of novel biologic therapeutic candidates, developed using protein engineering and Co.'s proprietary single domain antibody, or sdAb, platform. Co. has four programs in ongoing Phase 1 clinical trials, three for the treatment of various cancers, and one for Alpha-1 Antitrypsin Deficiency. Co.'s most advanced therapeutic candidate, INBRX-109, is a tetravalent death receptor 5, or DR5, agonist being evaluated in patients diagnosed with chondrosarcoma and mesotheliom. INBRX-106 is a hexavalent OX40 agonist developed for patients with locally advanced or metastatic solid tumors. Co. is also developing INBRX-105 and INNBRX-101.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
511,627 |
1,844,960 |
Total Buy Value |
$0 |
$0 |
$9,899,982 |
$49,899,839 |
Total People Bought |
0 |
0 |
1 |
1 |
Total Buy Transactions |
0 |
0 |
1 |
2 |
Total Shares Sold |
300,000 |
300,000 |
300,000 |
802,060 |
Total Sell Value |
$10,290,000 |
$10,290,000 |
$10,290,000 |
$22,636,854 |
Total People Sold |
1 |
1 |
1 |
4 |
Total Sell Transactions |
1 |
1 |
1 |
23 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Eckelman Living Trust Dated February 5, 2014 |
10% Owner |
|
2022-10-04 |
4 |
AS |
$24.67 |
$1,112,813 |
I/I |
(40,000) |
2,235,553 |
|
- |
|
Eckelman Living Trust Dated February 5, 2014 |
10% Owner |
|
2022-09-13 |
4 |
GA |
$0.00 |
$0 |
I/I |
160,000 |
160,000 |
|
- |
|
Eckelman Living Trust Dated February 5, 2014 |
10% Owner |
|
2022-09-13 |
4 |
GD |
$0.00 |
$0 |
I/I |
160,000 |
2,275,553 |
|
- |
|
Eckelman Living Trust Dated February 5, 2014 |
10% Owner |
|
2022-09-06 |
4 |
AS |
$14.86 |
$596,274 |
I/I |
(40,000) |
2,435,553 |
|
- |
|
Kayyem Jon Faiz |
Director |
|
2022-08-24 |
4 |
GD |
$0.00 |
$0 |
I/I |
11,900 |
3,262,301 |
|
- |
|
Kayyem Jon Faiz |
Director |
|
2022-08-05 |
4 |
GD |
$0.00 |
$0 |
I/I |
3,400 |
3,274,201 |
|
- |
|
Eckelman Living Trust Dated February 5, 2014 |
10% Owner |
|
2022-08-03 |
4 |
AS |
$18.47 |
$286,209 |
I/I |
(15,500) |
2,475,553 |
|
- |
|
Eckelman Living Trust Dated February 5, 2014 |
10% Owner |
|
2022-08-02 |
4 |
AS |
$17.70 |
$433,626 |
I/I |
(24,500) |
2,491,053 |
|
- |
|
Kayyem Jon Faiz |
Director |
|
2022-08-02 |
4 |
GA |
$0.00 |
$0 |
I/I |
50,000 |
25,000 |
|
- |
|
Kayyem Jon Faiz |
Director |
|
2022-08-02 |
4 |
GD |
$0.00 |
$0 |
I/I |
118,500 |
3,277,601 |
|
- |
|
Eckelman Living Trust Dated February 5, 2014 |
10% Owner |
|
2022-07-07 |
4 |
AS |
$17.17 |
$686,800 |
I/I |
(40,000) |
2,515,553 |
|
- |
|
Eckelman Living Trust Dated February 5, 2014 |
10% Owner |
|
2022-04-05 |
4 |
AS |
$25.04 |
$10,016 |
I/I |
(400) |
2,555,553 |
|
- |
|
Eckelman Living Trust Dated February 5, 2014 |
10% Owner |
|
2021-03-24 |
4 |
AS |
$19.02 |
$323,340 |
I/I |
(17,000) |
2,555,953 |
|
- |
|
Wagner Klaus W. |
Chief Medical Officer |
|
2021-02-17 |
4 |
AS |
$25.29 |
$494,647 |
D/D |
(19,559) |
215,150 |
|
- |
|
Eckelman Living Trust Dated February 5, 2014 |
10% Owner |
|
2021-02-16 |
4 |
AS |
$25.90 |
$440,300 |
I/I |
(17,000) |
2,572,953 |
|
- |
|
Wagner Klaus W. |
Chief Medical Officer |
|
2021-02-16 |
4 |
AS |
$24.32 |
$3,805,448 |
D/D |
(156,474) |
234,709 |
|
- |
|
Lappe Family Trust |
To be Verified |
|
2020-12-28 |
4 |
GA |
$0.00 |
$0 |
I/I |
500,000 |
500,000 |
|
- |
|
Lappe Family Trust |
To be Verified |
|
2020-12-28 |
4 |
GD |
$0.00 |
$0 |
I/I |
500,000 |
2,590,252 |
|
- |
|
Eckelman Living Trust Dated February 5, 2014 |
10% Owner |
|
2020-12-04 |
4 |
GA |
$0.00 |
$0 |
I/I |
160,000 |
80,000 |
|
- |
|
Eckelman Living Trust Dated February 5, 2014 |
10% Owner |
|
2020-12-04 |
4 |
GD |
$0.00 |
$0 |
I/I |
160,000 |
2,589,953 |
|
- |
|
Shabet Rose Sharon |
10% Owner |
|
2020-08-26 |
4 |
B |
$18.84 |
$3,409,866 |
I/I |
180,219 |
1,427,307 |
1.5 |
- |
|
Shabet Rose Sharon |
10% Owner |
|
2020-08-25 |
4 |
B |
$19.23 |
$1,651,687 |
I/I |
85,304 |
1,247,088 |
1.5 |
- |
|
Shabet Rose Sharon |
10% Owner |
|
2020-08-24 |
4 |
B |
$19.43 |
$897,001 |
I/I |
46,161 |
1,161,784 |
1.5 |
- |
|
Shabet Rose Sharon |
10% Owner |
|
2020-08-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,994,182 |
|
- |
|
Shah Rajeev M. |
10% Owner |
|
2020-08-21 |
4 |
A |
$0.00 |
$0 |
I/I |
2,129,003 |
2,129,003 |
|
- |
|
57 Records found
|
|
Page 2 of 3 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|